Alcoholic vs. Nonalcoholic Steatohepatitis: Vascular Branching Heterogeneity on Magnetic Resonance Imaging as a Diagnostic Marker

Background and Aims Distinguishing alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH) with biopsy alone is often difficult without a reliable clinical context. A novel finding on liver imaging, perivascular branching heterogeneity, has shown promise in distinguishing between these chronic liver diseases. Our study investigated the role of this finding on imaging to differentiate between ASH and NASH. The aim of this study was to determine the utility and reproducibility of this novel radiographic marker to help distinguish ASH from NASH. Methods This was a retrospective cohort study conducted between 2016 and 2020 in patients with both liver biopsy-confirmed steatohepatitis/chronic hepatitis and abdominal magnetic resonance imaging within 13 months of each other. Two radiologists, blinded to patient clinical history and diagnosis, categorized the appearance of the liver as: 1- homogeneity, 2- mild heterogeneity, 3- moderate heterogeneity, 4- possible perivascular branching, 5- definite perivascular branching. Results Of the 90 patients in the study, 60 were identified as NASH and 30 as ASH. The area under the curve (AUC) for both reader 1 and 2 when using the 5-point scale was 0.69 (CI: 0.56–0.82, p=0.006) and 0.72 (CI: 0.60–0.85, p=0.001), respectively. The positive predictive value (PPV) for identification of ASH when scoring 5 was 64.7% and 66.7% for reader 1 and 2, respectively. Interclass correlation coefficient was 0.74 in patients with ASH, indicating moderate reliability among both readers. Conclusions Identification of this perivascular branching pattern on imaging is a promising novel diagnostic marker that can be used with other methods to help distinguish between ASH and NASH.

[1]  Songtao Li,et al.  Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease , 2022, Nutrition & Metabolism.

[2]  O. Quehenberger,et al.  Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder , 2022, Metabolites.

[3]  V. Gnemmi,et al.  Combined alcoholic and non-alcoholic steatohepatitis , 2020, JHEP reports : innovation in hepatology.

[4]  Z. Younossi,et al.  Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States , 2020, Hepatology communications.

[5]  A. Singal,et al.  Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016 , 2019, JAMA.

[6]  M. Mahtab,et al.  Global Epidemiology of Chronic Liver Disease , 2018, Clinical Epidemiology of Chronic Liver Diseases.

[7]  O. Yokosuka,et al.  Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[8]  Z. Goodman,et al.  Epidemiology and natural history of non-alcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[9]  D. Kleiner,et al.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2016, Metabolism: clinical and experimental.

[10]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[11]  L. Henry,et al.  Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. , 2016, Gastroenterology.

[12]  C. Sirlin,et al.  Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study , 2015, Alimentary pharmacology & therapeutics.

[13]  A. Gamst,et al.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.

[14]  P. Angulo,et al.  Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities? , 2014, Current Hepatology Reports.

[15]  Z. Younossi,et al.  Mortality associated with alcohol‐related liver disease , 2013, Alimentary pharmacology & therapeutics.

[16]  D. Aguirre,et al.  Fatty liver: imaging patterns and pitfalls. , 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

[17]  D. Brenner,et al.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD , 2012, Alimentary pharmacology & therapeutics.

[18]  C. Kauffmann,et al.  Fatty liver deposition and sparing: a pictorial review , 2011, Insights into imaging.

[19]  D. Tiniakos,et al.  Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients. , 2009, Gastroenterologie clinique et biologique.

[20]  E. Brunt.  Pathology of fatty liver disease , 2007, Modern Pathology.

[21]  S. Sanderson,et al.  Utility of a new model to diagnose an alcohol basis for steatohepatitis. , 2006, Gastroenterology.

[22]  Claude B Sirlin,et al.  Imaging features of perivascular fatty infiltration of the liver: initial observations. , 2005, Radiology.

[23]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[24]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[25]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.

[26]  T. Starzl,et al.  The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. , 1975, Surgery, gynecology & obstetrics.